(Q35824478)

10 August 2017

1 reference

title

Does B cell depletion have a role to play in the treatment of systemic lupus erythematosus? (English)

1 reference

systemic lupus erythematosus

10 August 2017

0 references

3

D Isenberg

1 reference

10 August 2017

C Gorman

1

1 reference

PubMed ID

15230284

10 August 2017

M Leandro

series ordinal

2

1 reference

10 August 2017

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

13

1 reference

10 August 2017

5

1 reference

10 August 2017

312-316

1 reference

CD20: a regulator of cell-cycle progression of B lymphocytes

10 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Biological treatments for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Cytokines and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Immunopathogenesis of SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Workshop report on some new ideas about the treatment of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

An open study of B lymphocyte depletion in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Treatment of childhood autoimmune haemolytic anaemia with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

Restoration of erythropoiesis by rituximab in an adult patient with primary acquired pure red cell aplasia refractory to conventional treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1018OA

10.1191/0961203304LU1018OA

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15230284